Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) EPS (Basic) (2019 - 2025)

Silo Pharma's EPS (Basic) history spans 7 years, with the latest figure at -$0.08 for Q3 2025.

  • For Q3 2025, EPS (Basic) rose 63.64% year-over-year to -$0.08; the TTM value through Sep 2025 reached -$0.91, up 23.53%, while the annual FY2024 figure was -$1.19, 0.83% up from the prior year.
  • EPS (Basic) for Q3 2025 was -$0.08 at Silo Pharma, up from -$0.19 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.06 in Q3 2021 and bottomed at -$0.58 in Q4 2022.
  • The 5-year median for EPS (Basic) is -$0.29 (2023), against an average of -$0.27.
  • The largest annual shift saw EPS (Basic) surged 899.15% in 2021 before it plummeted 6402.43% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at -$0.47 in 2021, then decreased by 23.4% to -$0.58 in 2022, then skyrocketed by 34.48% to -$0.38 in 2023, then dropped by 7.89% to -$0.41 in 2024, then surged by 80.49% to -$0.08 in 2025.
  • Per Business Quant, the three most recent readings for SILO's EPS (Basic) are -$0.08 (Q3 2025), -$0.19 (Q2 2025), and -$0.23 (Q1 2025).